Article Details
Retrieved on: 2025-09-13 11:52:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
While monoclonal antibodies targeting PD-1/PD-L1 interaction have revolutionized cancer treatment, their limitations—including resistance ...
Article found on: bioengineer.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here